MedAdvisor Ltd (ASX: MDR) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

MedAdvisor Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $151.29 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 550.15 million
Earnings per share -0.018
Dividend per share N/A
Year To Date Return 27.91%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • MedAdvisor Ltd (ASX: MDR)
    Latest News

    a woman
    Share Market News

    3 ASX medical tech shares surging higher today

    Here are 3 ASX shares in the fast-growing medical tech sector that have seen gains of around 5% so far…

    Read more »

    a woman
    Share Gainers

    Medadvisor share price rockets 28% higher on U.S. update

    The Medadvisor Ltd (ASX:MDR) share price was one of the best performers on the Australian share market on Thursday...

    Read more »

    a woman
    Share Market News

    SaaS player MedAdvisor Ltd raises $17 million for growth push

    MedAdvisor is a little-known tech and healthcare small cap.

    Read more »

    a woman
    ⏸️ Investing

    Why the MedAdvisor Ltd (ASX:MDR) share price is up 20% today

    MedAdvisor Ltd (ASX:MDR) jumps 20% to 4.8 cents in morning trade following the announcement that it has signed a Co-Marketing and Licence…

    Read more »

    a woman
    ⏸️ Investing

    These tech shares are flying

    These three tech shares are making investors happy…

    Read more »

    a woman
    ⏸️ Investing

    3 Exciting Med-Tech Stocks For Asthma: Are They Any Good?

    Technology to treat chronic disease can be very profitable, but that doesn't mean every company that aims to treat chronic…

    Read more »

    MDR ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About MedAdvisor Ltd

    MedAdvisor Ltd is engaged in the development and deployment of the MedAdvisor medication and adherence platform. The MedAdvisor platform is focused on improving health outcomes by connecting health professionals with their patients using mobile and web technologies. It has five reporting segments: ANZ Operations, USA Operations, UK Operations, Asia Operations, and Corporate. The company derives majority of its revenues from AU Operations.

    MDR Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    28 Mar 2024 $0.28 $0.00 0.00% 74,263 $0.28 $0.28 $0.27
    27 Mar 2024 $0.28 $0.00 0.00% 49,176 $0.28 $0.28 $0.27
    26 Mar 2024 $0.28 $0.01 3.77% 69,468 $0.27 $0.29 $0.27
    25 Mar 2024 $0.27 $0.02 8.00% 72,147 $0.25 $0.27 $0.25
    22 Mar 2024 $0.25 $-0.01 -3.92% 353,466 $0.26 $0.26 $0.25
    21 Mar 2024 $0.26 $-0.01 -3.85% 434,899 $0.26 $0.26 $0.26
    20 Mar 2024 $0.26 $-0.02 -7.27% 316,089 $0.28 $0.28 $0.26
    19 Mar 2024 $0.28 $-0.02 -6.90% 337,750 $0.28 $0.29 $0.27
    18 Mar 2024 $0.29 $-0.01 -3.33% 193,626 $0.30 $0.30 $0.29
    15 Mar 2024 $0.30 $0.01 3.39% 176,216 $0.30 $0.30 $0.30
    14 Mar 2024 $0.30 $0.00 0.00% 180,946 $0.29 $0.30 $0.29
    13 Mar 2024 $0.30 $0.00 0.00% 55,716 $0.30 $0.30 $0.29
    12 Mar 2024 $0.30 $0.00 0.00% 2,011,893 $0.30 $0.30 $0.29
    11 Mar 2024 $0.30 $-0.01 -3.33% 49,784 $0.30 $0.30 $0.30
    08 Mar 2024 $0.30 $0.01 3.39% 47,582 $0.30 $0.30 $0.30
    07 Mar 2024 $0.30 $-0.01 -3.33% 110,486 $0.30 $0.30 $0.30
    06 Mar 2024 $0.30 $-0.01 -3.23% 210,714 $0.30 $0.31 $0.30
    05 Mar 2024 $0.31 $0.01 3.33% 256,040 $0.31 $0.32 $0.30
    04 Mar 2024 $0.30 $0.01 3.45% 339,025 $0.29 $0.32 $0.29
    01 Mar 2024 $0.29 $-0.03 -9.52% 389,768 $0.32 $0.32 $0.29
    29 Feb 2024 $0.32 $-0.02 -6.06% 476,846 $0.34 $0.35 $0.31
    28 Feb 2024 $0.33 $0.04 13.79% 7,115,845 $0.31 $0.33 $0.31
    27 Feb 2024 $0.29 $-0.01 -3.39% 239,933 $0.30 $0.31 $0.28

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    08 Nov 2023 Jim Xenos Sell 6,846,955 $1,232,452
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Catherine (Kate) Jane Hill Non-Executive Director May 2023
    Ms Hill is auditor and business advisor with over 30 years' experience of working with privately owned and ASX-listed companies across a range of business issues. A former senior partner and first female board member of top 4 accounting firm Deloitte, she has in recent years turned her focus, her energies, and experience into Non-Executive Director roles. She is an director of small to mid-cap companies listed on ASX and other global exchanges, with a track record in change involving new business models, new markets, and new technologies. She is chair of Risk Committee amd member of People Committee.
    Mr Jim Xenos Non-Executive Director Nov 2015
    Mr Xenos is currently the Chief Executive Officer of NostraData Pty Limited, which he co-founded in 2010. Prior to co-founding NostraData, Jim held several Associate Director positions with GlaxoSmithKline PLC. Jim was also the Head of Retail at Sigma Healthcare Limited for Herron Pharmaceuticals. She is a member of Audit committee and chair of people committee.
    Ms Linda Jenkinson Non-Executive ChairmanNon-Executive Director Feb 2022
    Ms Jenkinson has 30 years of executive management, strategic consulting, and governance experience. She was the Co-founder and CEO of two technology-enabled companies, DMSC and LesConcierges. She is an experienced CEO who was the first woman CEO/ Co-founder to take her company public on the NASDAQ. She sold her second company to the Accor Hotel Group in 2016. Prior to DMSC, Linda was a Partner at A.T. Kearney, where she helped build their global Financial Institutions Practice. During the last three years, Linda served on the Board of Air New Zealand. She is a member of the Risk and People Committee.
    Ms Sandra Margaret Hook Non-Executive Director Jan 2016
    Ms Hook is an experienced board director with a non-executive career spanning diverse sectors including communications; IT, technology, and digital; health tech; tourism; government; research; and policy. She brings experience in transformation and growth gained in roles including Managing Director, CEO, COO, and marketing director for some of Australia's largest media organisations, including News Limited, Foxtel, and FairFax. Sandra's board experience spans listed, private, and government boards. She is Chair of Risk Committee.
    Mr Lucas Merrow Non-Executive Director Aug 2021
    Mr Merrow co-founded and served as the Chief Executive Officer of Eliza Corporation-the leader in health engagement management and patient communications. Eliza Corporation was later acquired. Prior to the founding of Eliza Corporation, Lucas co-founded and served as the Chief Operating Officer of Adheris Health, a leading firm in prescription adherence and patient education programs in the United States. MedAdvisor acquired Adheris Health in November 2020. He is Member of People Committee.
    Mr Richard (Rick) Ratliff Chief Executive OfficerManaging Director Jul 2022
    Mr Ratliff spent over 30 years in the healthcare and pharmaceutical technology sector in key markets in which MedAdvisor Solutions operates. He has led the development of a number of large-scale technology-enabled healthcare businesses within global organisations such as IBM and Accenture as well as via start-up and early-stage businesses, including Healthvision, Surescripts, and ConnectiveRx. Rick also worked with the Australian federal government to develop and deliver My Health Record, the leading online EHR available to all Australian citizens. He is a member of People Committee.
    Mr Anthony Tassone Non-Executive Director Jul 2022
    Mr Tassone is a community pharmacist and has been a proprietor of community pharmacies since 2006 in outer southeastern Melbourne. He has been the Victorian Branch President of the Pharmacy Guild of Australia since 2013. Over the past decade, Anthony has served on a range of advisory boards for multinational pharmaceutical companies and had advisory roles with state and federal governments. In 2021, Anthony was appointed the National Vice President of Health Economics and Policy for the Pharmacy Guild of Australia. He is a member of Risk Committee.
    Mr Kevin Hutchinson Non-Executive Director Nov 2022
    Mr Hutchinson is an entrepreneur with 30 years of experience in the tech industry. He has built and grown companies that deliver innovative services by using disruptive technology. He also has seen great success in his ability to accelerate growth by hiring and developing teams that drive exceptional results. He has served in numerous C-level executive roles, including CEO and COO, as well as a number of non-executive board appointments. Kevin is CEO and Director of AXL Health and on the Board of Matrix Analytics dba eon Health. He is a member of Risk Committee.
    Mr Brett Magun Non-Executive Director May 2023
    Mr Magun has over 20 years of experience as a diversified attorney licensed to practice in Massachusetts and New York. He provides legal advice to C-level suite and boards of directors regarding strategic corporate transactions. His legal background includes M&A, strategic partnerships, employment issues, vendor contracts and management, privacy and regulatory compliance, pre-litigation and risk management, intellectual property (IP), marketing, external communications, and general legal matters.
    Ms Ancila Desai Chief Financial OfficerCompany Secretary Feb 2023
    -
    Mr Anshu Raghuvanshi Joint Company Secretary Mar 2023
    -
    Ancila Desai Chief Financial OfficerCompany Secretary
    -
    Anshu Raghuvanshi Joint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Guild Group Holdings Limited 94,905,130 17.38%
    National Nominees Limited 68,036,011 12.46%
    Hsbc Custody Nominees (Australia) Limited 47,308,994 8.66%
    Cotiviti Inc 43,999,999 8.06%
    Citicorp Nominees Pty Limited 37,328,343 6.84%
    J P Morgan Nominees Australia Pty Limited 30,623,011 5.61%
    Ebos Ph Pty Ltd 26,459,627 4.85%
    Bond Street Custodians Limited <Salter D79836 A/C> 17,320,000 3.17%
    Kojent Pty Ltd <Kojent A/C> 13,693,911 2.51%
    Romida Enterprises Pty Ltd <Romida Family A/C> 12,642,935 2.32%
    Wavey Industries Pty Ltd <Josh Swinnerton Family A/C> 10,785,259 1.97%
    UBS Nominees Pty Ltd 8,865,658 1.62%
    Indcorp Consulting Group Pty Limited <Superannuation Fund A/C> 5,000,000 0.92%
    Bnp Paribas Noms Pty Ltd <Drp> 4,505,429 0.82%
    Gread Management Pty Limited <The A G & R R Family A/C> 4,106,188 0.75%
    Provare Pty Ltd <Provare Investment A/C> 3,743,419 0.69%
    Dr Christopher Harold Benton 3,000,000 0.55%
    Tagdime Pty Ltd <Ian M Davison P/L S/F A/C> 2,634,322 0.48%
    DMX Capital Partners Limited 2,351,551 0.43%
    Capital Concerns Pty Limited <Logue Family Super Fund A/C> 2,197,092 0.40%

    Profile

    since

    Note